Diastolic dysfunction diagnosed by tissue Doppler imaging in cirrhotic patients: Prevalence and its possible relationship with clinical outcome

被引:18
作者
Falletta, Calogero [1 ]
Fili, Daniela [2 ]
Nugara, Cinzia [3 ]
Di Gesaro, Gabriele [1 ]
Mina, Chiara [1 ]
Baravoglia, Cesar Mario Hernandez [1 ]
Romano, Giuseppe [1 ]
Scardulla, Cesare [1 ]
Tuzzolino, Fabio [4 ]
Vizzini, Giovanni [2 ]
Clemenza, Francesco [1 ]
机构
[1] Mediterranean Inst Transplantat & Adv Specialized, Dept Treatment & Study Cardiothorac Dis & Cardiot, Cardiol Unit, Palermo, Italy
[2] Mediterranean Inst Transplantat & Adv Specialized, Dept Treatment & Study Abdominal Dis & Abdominal, Hepatol Unit, Palermo, Italy
[3] AOUP Paolo Giaccone, Div Cardiol, I-90127 Palermo, Italy
[4] Mediterranean Inst Transplantat & Adv Specialized, Res Off, Palermo, Italy
关键词
Cirrhosis; Diastolic dysfunction; Tissue Doppler imaging; INTRAHEPATIC PORTOSYSTEMIC SHUNT; LIVER-TRANSPLANTATION; CARDIOMYOPATHY; SEVERITY; DISEASE; ECHOCARDIOGRAPHY; RECOMMENDATIONS; ABNORMALITIES; PROLONGATION; GALECTIN-3;
D O I
10.1016/j.ejim.2015.10.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cirrhotic cardiomyopathy has been characterized by impaired contractile response to stress and/or altered diastolic relaxation, with electrophysiological abnormalities in the absence of known cardiac disease. However, the clinical significance of diastolic dysfunction (DDF) in cirrhotic patients has not been clarified. Methods: We studied 84 cirrhotic patients with normal systolic function to evaluate the prevalence of DDF using tissue Doppler imaging, and to investigate the possible correlation of DDF with outcomes (hospitalization, death) and with the specific causes of death. Results: The mean follow-up was 10 +/- 8 months. DDF was diagnosed in 22 patients (26.2%). Patients with DDF more frequently had ascites (90.9% vs. 64.5 %; p = 0.026), lower levels of albumin (OR: 5.39; p = 0.004), higher NT-proBNP levels, and longer QTc interval (464 +/- 23 ms vs. 452 +/- 30 ms; p = 0.039). At follow-up, patients with DDF did not have a higher incidence of adverse events in terms of hospitalization and death. Conclusions: The presence of diastolic dysfunction has not been found to be clearly associated with outcome, and prognosis has been determined primarily by the severity of liver disease. (C) 2015 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:830 / 834
页数:5
相关论文
共 31 条
  • [1] Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis
    Alexopoulou, Alexandra
    Papatheodoridis, George
    Pouriki, Sophia
    Chrysohoou, Christina
    Raftopoulos, Leonidas
    Stefanadis, Christodoulos
    Pectasides, Dimitrios
    [J]. TRANSPLANT INTERNATIONAL, 2012, 25 (11) : 1174 - 1181
  • [2] Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation
    Bal, JS
    Thuluvath, PJ
    [J]. LIVER INTERNATIONAL, 2003, 23 (04) : 243 - 248
  • [3] Q-T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors
    Bernardi, M
    Calandra, S
    Colantoni, A
    Trevisani, F
    Raimondo, ML
    Sica, G
    Schepis, F
    Mandini, M
    Simoni, P
    Contin, M
    Raimondo, G
    [J]. HEPATOLOGY, 1998, 27 (01) : 28 - 34
  • [4] Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt
    Cazzaniga, Massimo
    Salerno, Francesco
    Pagnozzi, Giovanni
    Dionigi, Elena
    Visentin, Stefania
    Cirello, Ilaria
    Meregaglia, Daniele
    Nicolini, Antonio
    [J]. GUT, 2007, 56 (06) : 869 - 875
  • [5] The fibrosis marker galectin-3 and outcome in the general population
    de Boer, R. A.
    van Veldhuisen, D. J.
    Gansevoort, R. T.
    Kobold, A. C. Muller
    van Gilst, W. H.
    Hillege, H. L.
    Bakker, S. J. L.
    van der Harst, P.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2012, 272 (01) : 55 - 64
  • [6] Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
    de Boer, Rudolf A.
    Lok, Dirk J. A.
    Jaarsma, Tiny
    van der Meer, Peter
    Voors, Adriaan A.
    Hillege, Hans L.
    van Veldhuisen, Dirk J.
    [J]. ANNALS OF MEDICINE, 2011, 43 (01) : 60 - 68
  • [7] Fouad YM, 2014, WORLD J HEPATOL, V6, P41, DOI 10.4254/wjh.v6.i1.41
  • [8] Galectin-3 regulates myofibroblast activation and hepatic fibrosis
    Henderson, NC
    Mackinnon, AC
    Farnworth, SL
    Poirier, F
    Russo, FP
    Iredale, JP
    Haslett, C
    Simpson, KJ
    Sethi, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (13) : 5060 - 5065
  • [9] Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease
    Henriksen, JH
    Gotze, JP
    Fuglsang, S
    Christensen, E
    Bendtsen, F
    Moller, S
    [J]. GUT, 2003, 52 (10) : 1511 - 1517
  • [10] Kazan kov K, 2011, LIVER INT, P434